Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Five Prime TherapeuticsIDEAYA BiosciencesMannKindSyndax PharmaceuticalsKadmon
SymbolNASDAQ:FPRXNASDAQ:IDYANASDAQ:MNKDNASDAQ:SNDXNYSE:KDMN
Price Information
Current Price$5.50$7.21$1.05$9.09$2.56
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$21.3333$16.3333$3.00$15.6667$9.1675
% Upside from Price Target287.88% upside126.54% upside185.71% upside72.35% upside258.11% upside
Trade Information
Market Cap$201.60 million$152.52 million$200.93 million$246.30 million$321.11 million
Beta2.67N/A2.382.412.07
Average Volume479,29429,7051,869,258160,5871,292,410
Sales & Book Value
Annual Revenue$49.87 millionN/A$27.86 million$1.52 million$1.40 million
Price / Sales3.98N/A7.08162.07236.76
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$7.48 per shareN/A($1.10) per share$2.14 per share$0.41 per share
Price / Book0.74N/A-0.954.256.24
Profitability
Net Income$-140,450,000.00N/A$-86,970,000.00$-73,960,000.00$-54,250,000.00
EPS($4.13)N/A($0.59)($2.92)($1.03)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-683.89%N/A-170.82%-4,539.55%-2,509.88%
Return on Equity (ROE)-54.87%N/AN/A-107.48%-91.12%
Return on Assets (ROA)-44.40%N/A-90.43%-71.52%-39.97%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%N/AN/A0.01%0.60%
Current Ratio10.41%N/A0.89%6.24%3.89%
Quick Ratio10.41%N/A0.85%6.24%3.85%
Ownership Information
Institutional Ownership Percentage86.94%N/A26.96%62.78%75.41%
Insider Ownership Percentage6.40%N/A1.02%8.30%2.85%
Miscellaneous
Employees2095622538116
Shares Outstanding36.06 million19.48 million187.78 million27.10 million129.48 million
Next Earnings Date8/14/2019 (Estimated)N/A8/1/2019 (Estimated)8/6/2019 (Estimated)8/8/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 Five Prime TherapeuticsIDEAYA BiosciencesMannKindSyndax PharmaceuticalsKadmon

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel